{
    "nctId": "NCT01306188",
    "briefTitle": "Prognostic Value of Divpenia and CD4 Count in Relapsed Breast or Lung Cancer Patients",
    "officialTitle": "Study of Prognostic Value of T Cell Receptor Diversity and CD4 Lymphopenia in First Relapse Breast or Lung Cancer Patients",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Lung Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 179,
    "primaryOutcomeMeasure": "Analyse the prognostic value of divpenia",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \u2265 18 years old,\n* Patients with an histologically proven, inoperable breast or lung tumour,\n* Metastatic disease before the start of any chemotherapy,\n* Signed written informed consent form,\n* Covered by a medical insurance,\n* Patient accepting the conservation of biological samples,\n* Locally advanced incurable disease (only breast tumour).\n\nExclusion Criteria:\n\n* Hematological tumour,\n* Auto-immune disease (including HIV-positive - AIDS stage) or patients with immunosuppressive therapy,\n* Metastatic disease that had progressed after a first line chemotherapy,\n* Pregnant or lactating female or female of child-bearing potential not employing adequate contraception,\n* Patient deprived of liberty by a judicial or administrative,\n* Adult protected by law.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}